Transthyretin binding to A-Beta peptide - Impact on A-Beta fibrillogenesis and toxicity

FEBS Letters

Volumn 582, Issue 6, 2008, Pages 936-942

  Costa, R ^a   Goncalves A ^a   Saraiva, M J ^a,b   Cardoso, I ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

A Beta peptide; Alzheimer's disease; Disrupter; Inhibitor; Neuroprotector; Transthyretin

Indexed keywords

A BETA PEPTIDE; LIGAND; OLIGOMER; PEPTIDE DERIVATIVE; PREALBUMIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; BINDING COMPETITION; CONTROLLED STUDY; FIBER; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN VARIANT; SENILE PLAQUE; TRANSMISSION ELECTRON MICROSCOPY;

EID: 40149086952     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2008.02.034     Document Type: Article

References (35)

1. M. Bothwell E. Giniger Alzheimer’s disease: neurodevelopment converges with neurodegeneration Cell 102 2000 271 2733
2. D.J. Selkoe Alzheimer disease: mechanistic understanding predicts novel therapies Ann. Intern. Med. 140 2004 627 638
3. Y. Verdier M. Zarandi B. Penke Amyloid beta-peptide interactions with neuronal and glial cell plasma membrane: binding sites and implications for Alzheimer’s disease J. Pept. Sci. 10 2004 229 248
4. A.L. Schwarzman L. Gregori M.P. Vitek S. Lyubski W.J. Strittmatter Transthyretin sequesters amyloid beta protein and prevents amyloid formation Proc. Natl. Acad. Sci. 91 1994 8368 8372
5. V.P. Chauhan I. Ray A. Chauhan H.M. Wisniewski Binding of gelsolin, a secretory protein, to amyloid beta-protein Biochem. Biophys. Res. Commun. 258 1999 241 246
6. E. Carro J.L. Trejo T. Gomez-Isla D. LeRoith I. Torres-Aleman Serum insulin-like growth factor I regulates brain amyloid-beta levels Nat. Med. 8 2002 1390 1397
7. T.D. Stein J.A. Johnson Lack of neurodegeneration in transgenic mice overexpressing mutant amyloid precursor protein is associated with increased levels of transthyretin and the activation of cell survival pathways J. Neurosci. 22 2002 7380 7388
8. T.D. Stein N.J. Anders C. DeCarli S.L. Chan M.P. Mattson J.A. Johnson Neutralization of transthyretin reverses the neuroprotective effects of secreted amyloid precursor protein (APP) in APPSW mice resulting in tau phosphorylation and loss of hippocampal neurons: support for the amyloid hypothesis J. Neurosci. 24 2004 7707 7717
9. S.H. Choi S.N. Leight V.M. Lee T. Li P.C. Wong J.A. Johnson M.J. Saraiva S.S. Sisodia Accelerated A-Beta deposition in APPswe/PS1deltaE9 mice with hemizygous deletions of TTR (transthyretin) J. Neurosci. 27 2007 7006 7010
10. D.R. Soprano J. Herbert K.J. Soprano E.A. Schon D.S. Goodman Demonstration of transthyretin mRNA in the brain and other extrahepatic tissues in the rat J. Biol. Chem. 260 1985 11793 11798
11. K.A. Woeber S.H. Ingbar The contribution of thyroxine-binding prealbumin to the binding of thyroxine in human serum, as assessed by immunoadsorption J. Clin. Invest. 47 1968 1710 1721
12. A.L. Schwarzman D. Goldgaber Interaction of transthyretin with amyloid beta-protein: binding and inhibition of amyloid formation Ciba Found. Symp. 199 1996 146 160
13. C.D. Link Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans Proc. Natl. Acad. Sci. USA 92 1995 9368 9372
14. J.A. Palha P. Moreira T. Wisniewski B. Frangione M.J. Saraiva Transthyretin gene in Alzheimer’s disease patients Neurosci. Lett. 204 1996 212 214
15. H. Furuya M.J. Saraiva M.A. Gawinowicz I.L. Alves P.P. Costa H. Sasaki I. Goto Y. Sakaki Production of recombinant human transthyretin with biological activities toward the understanding of the molecular basis of familial amyloidotic polyneuropathy (FAP) Biochemistry 30 1991 2415 2421
16. M.R. Almeida A.M. Damas M.C. Lans A. Brouwer M.J. Saraiva Thyroxine binding to transthyretin Met 119. Comparative studies of different heterozygotic carriers and structural analysis Endocrine 6 1997 309 315
17. O.H. Lowry N.J. Rosenbrough A.L. Farr J. Randall Protein measurement with the Folin phenol reagent J. Biol. Chem. 193 1951 265 275
18. M.M. Sousa S.D. Yan D. Stern M.J. Saraiva Interaction of the receptor for advanced glycation end products (RAGE) with transthyretin triggers nuclear transcription factor kB (NF-kB) activation Lab. Invest. 80 2000 1101 1110
19. M.R. Almeida I.L. Alves H. Terazaki Y. Ando M.J. Saraiva Comparative studies of two transthyretin variants with protective effects on familial amyloidotic polyneuropathy: TTR R104H and TTR T119M Biochem. Biophys. Res. Commun. 21 2000 1024 1028
20. I. Cardoso C.S. Goldsbury S.A. Müller V. Olivieri S. Wirtz A.M. Damas U. Aebi M.J. Saraiva Transthyretin fibrillogenesis entails the assembly of monomers: a molecular model for in vitro assembled transthyretin amyloid-like fibrils J. Mol. Biol. 317 2002 683 695
21. G. Mamikonyan M. Necula M. Mkrtichyan A. Ghochikyan I. Petrushina N. Movsesyan E. Mina A. Kiyatkin C.G. Glabe D.H. Cribbs M.G. Agadjanyan Anti-Abeta 1–11 antibody binds to different beta-amyloid species, inhibits fibril formation, and disaggregates preformed fibrils but not the most toxic oligomers J. Biol. Chem. 282 2007 22376 22386
22. K. Tsuzuki R. Fukatsu H. Yamaguchi M. Tateno K. Imai N. Fujii T. Yamauchi Transthyretin binds amyloid beta peptides, Abeta1–42 and Abeta1–40 to form complex in the autopsied human kidney – possible role of transthyretin for Abeta sequestration Neurosci. Lett. 281 2000 171 174
23. J.M. Serot D. Christmann T. Dubost M. Couturier Cerebrospinal fluid transthyretin: aging and late onset Alzheimer’s disease J. Neurol. Neurosurg. Psychiatry 63 1997 506 508
24. E.M. Castano A.E. Roher C.L. Esh T.A. Kokjohn T. Beach Comparative proteomics of cerebrospinal fluid in neuropathologically-confirmed Alzheimer’s disease and non-demented elderly subjects Neurol. Res. 28 2006 155 163
25. A.L. Schwarzman M. Tsiper H. Wente A. Wang M.P. Vitek V. Vasiliev D. Goldgaber Amyloidogenic and anti-amyloidogenic properties of recombinant transthyretin variants Amyloid 11 2004 1 9
26. L. Liu R.M. Murphy Kinetics of inhibition of beta-amyloid aggregation by transthyretin Biochemistry 45 2006 15702 15709
27. M.P. Sebastiao M.J. Saraiva A.M. Damas The crystal structure of amyloidogenic Leu55 → Pro transthyretin variant reveals a possible pathway for transthyretin polymerization into amyloid fibrils J. Biol. Chem. 273 1998 24715 24722
28. M.P. Sebastião V. Lamzin M.J. Saraiva A.M. Damas Transthyretin stability as a key factor in amyloidogenesis: X-ray analysis at atomic resolution J. Mol. Biol. 306 2001 733 744
29. I.L. Alves M.T. Hays M.J. Saraiva Comparative stability and clearance of Met30 transthyretin and Met119 transthyretin Eur. J. Biochem. 249 1997 662 668
30. E.A. Eckman D.K. Reed C.B. Eckman Degradation of the Alzheimer’s amyloid beta peptide by endothelin-converting enzyme J. Biol. Chem. 276 2001 24540 24548
31. T. Shirahama M. Skinner P. Westermark A. Rubinow A.S. Cohen A. Brun T.L. Kemper Senile cerebral amyloid. Prealbumin as a common constituent in the neuritic plaque, in the neurofibrillary tangle, and in the microangiopathic lesion Am. J. Pathol. 107 1982 41 50
32. P. Eikelenboom F.C. Stam An immunohistochemical study on cerebral vascular and senile plaque amyloid in Alzheimer’s dementia Virchow Arch. B: Cell Pathol. Incl. Mol. Pathol. 47 1984 17 25
33. J.C. Sousa I. Cardoso F. Marques M.J. Saraiva J.A. Palha Transthyretin and Alzheimer’s disease: where in the brain? Neurobiol. Aging 28 2006 713 718
34. P.J. Crouch S.M. Harding A.R. White J. Camakaris A.I. Bush C.L. Masters Mechanisms of A beta mediated neurodegeneration in Alzheimer’s disease Int. J. Biochem. Cell Biol. 40 2008 181 198
35. Y. Liu R. Dargusch D. Schubert Beta amyloid toxicity does not require RAGE protein Biochem. Biophys. Res. Commun. 237 1997 37 40